← Back to Clinical Trials
Recruiting NCT07234565

NCT07234565 SOCIAL_HF: Improving Social Frailty Through Interactive Learning

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07234565
Status Recruiting
Phase
Sponsor The University of Hong Kong
Condition Heart Failure
Study Type INTERVENTIONAL
Enrollment 208 participants
Start Date 2025-09-15
Primary Completion 2027-09-30

Eligibility & Interventions

Sex All sexes
Min Age 60 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
SOCIAL_HFSelf-study heart failure self-care manual

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 208 participants in total. It began in 2025-09-15 with a primary completion date of 2027-09-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to learn whether the WeChat-based program "Social Optimization Chat for Interactive Learning for Heart Failure" (SOCIAL\_HF) can improve social frailty in elderly patients with heart failure. The main questions it aims to answer are: Can a 6-week WeChat online group interactive learning program (SOCIAL\_HF) improve social frailty? Does the intervention enhance self-care abilities, social participation, and perceived social support? Researchers will compare SOCIAL\_HF to usual care (self-study heart failure self-care manual) to assess whether SOCIAL\_HF can improve social functioning. Participants will: Engage in weekly WeChat video meetings for six weeks (Participate in peer sharing and collaborative tasks). Complete daily health task check-ins. Access online self-care resources.

Eligibility Criteria

Inclusion Criteria: 1. 60 years old and above; 2. Live in the community; 3. a definitive diagnosis of heart failure based on the Framingham Heart Failure Diagnostic Criteria; 4. a diagnosis of heart failure for 6 months or longer; 5. evidence of social pre-frailty or frailty, determined by the SFS-8 score ≥ 2; (6) possession of a smartphone and experience using WeChat; (7) be able to read and write Chinese. Exclusion Criteria: 1. severe cognitive impairment or dementia; 2. known mental illnesses; 3. any communication barriers may hinder participation in SOCIAL\_HF, such as illiteracy, reading disabilities, speak local dialect only, and difficulties in language comprehension; 4. any sensory impairments that may affect learning or interaction with others on WeChat, including untreated severe hearing loss and vision impairments; 5. are currently participating in other intervention studies.

Contact & Investigator

Central Contact

Miao Miao

✉ marymiao@connect.hku.hk

📞 852-51697980

Principal Investigator

Miao Miao, MN, RN

PRINCIPAL INVESTIGATOR

School of Nursing, University of Hong Kong

Frequently Asked Questions

Who can join the NCT07234565 clinical trial?

This trial is open to participants of all sexes, aged 60 Years or older, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07234565 currently recruiting?

Yes, NCT07234565 is actively recruiting participants. Contact the research team at marymiao@connect.hku.hk for enrollment information.

Where is the NCT07234565 trial being conducted?

This trial is being conducted at Shanghai, China, Shanghai, China, Shanghai, China.

Who is sponsoring the NCT07234565 clinical trial?

NCT07234565 is sponsored by The University of Hong Kong. The principal investigator is Miao Miao, MN, RN at School of Nursing, University of Hong Kong. The trial plans to enroll 208 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology